Human intestinal microbiota composition is associated with local and systemic inflammation in obesity

  • Froukje J. Verdam
    Department of General Surgery, NUTRIM Maastricht University Medical Center Maastricht The Netherlands
  • Susana Fuentes
    Laboratory of Microbiology Wageningen University Wageningen The Netherlands
  • Charlotte de Jonge
    Department of General Surgery, NUTRIM Maastricht University Medical Center Maastricht The Netherlands
  • Erwin G. Zoetendal
    Laboratory of Microbiology Wageningen University Wageningen The Netherlands
  • Runi Erbil
    Department of General Surgery, NUTRIM Maastricht University Medical Center Maastricht The Netherlands
  • Jan Willem Greve
    Department of General Surgery, NUTRIM Maastricht University Medical Center Maastricht The Netherlands
  • Wim A. Buurman
    Department of General Surgery, NUTRIM Maastricht University Medical Center Maastricht The Netherlands
  • Willem M. de Vos
    Laboratory of Microbiology Wageningen University Wageningen The Netherlands
  • Sander S. Rensen
    Department of General Surgery, NUTRIM Maastricht University Medical Center Maastricht The Netherlands

書誌事項

公開日
2013-06-22
権利情報
  • http://onlinelibrary.wiley.com/termsAndConditions#vor
DOI
  • 10.1002/oby.20466
公開者
Wiley

この論文をさがす

説明

<jats:sec><jats:title>Objective</jats:title><jats:p>Intestinal microbiota have been suggested to contribute to the development of obesity, but the mechanism remains elusive. The relationship between microbiota composition, intestinal permeability, and inflammation in nonobese and obese subjects was investigated.</jats:p></jats:sec><jats:sec><jats:title>Design and Methods</jats:title><jats:p>Fecal microbiota composition of 28 subjects (BMI 18.6‐60.3 kg m<jats:sup>−2</jats:sup>) was analyzed by a phylogenetic profiling microarray. Fecal calprotectin and plasma C‐reactive protein levels were determined to evaluate intestinal and systemic inflammation. Furthermore, HbA<jats:sub>1c</jats:sub>, and plasma levels of transaminases and lipids were analyzed. Gastroduodenal, small intestinal, and colonic permeability were assessed by a multisaccharide test.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Based on microbiota composition, the study population segregated into two clusters with predominantly obese (15/19) or exclusively nonobese (9/9) subjects. Whereas intestinal permeability did not differ between clusters, the obese cluster showed reduced bacterial diversity, a decreased Bacteroidetes/Firmicutes ratio, and an increased abundance of potential proinflammatory Proteobacteria. Interestingly, fecal calprotectin was only detectable in subjects within the obese microbiota cluster (<jats:italic>n</jats:italic> = 8/19, <jats:italic>P</jats:italic> = 0.02). Plasma C‐reactive protein was also increased in these subjects (<jats:italic>P</jats:italic> = 0.0005), and correlated with the Bacteroidetes/Firmicutes ratio (<jats:italic>r</jats:italic><jats:sub>s</jats:sub> = −0.41, <jats:italic>P</jats:italic> = 0.03).</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Intestinal microbiota alterations in obese subjects are associated with local and systemic inflammation, suggesting that the obesity‐related microbiota composition has a proinflammatory effect.</jats:p></jats:sec>

収録刊行物

  • Obesity

    Obesity 21 (12), E607-, 2013-06-22

    Wiley

被引用文献 (5)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ